Generic Companies Begin to Take out Patents to Protect Their Products: Generics: Global Industry Guide.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26488) has announced the addition of Generics: Global Industry Guide to their offering. The Generics: Global Industry Guide is an essential resource for top-level data and analysis covering the generics industry. It includes detailed data on market size and segmentation, textual tex·tu·al adj. Of, relating to, or conforming to a text. tex  tu·al·ly adv. analysis of the
key trends and competitive landscape, and profiles of the leading
companies. This incisive incisive /in·ci·sive/ (-si´siv)1. having the power or quality of cutting. 2. pertaining to the incisor teeth. in·ci·sive adj. 1. Having the power to cut. report provides expert analysis on a global, regional and country basis. Scope of the Report - Contains an executive summary and data on value and segmentation - Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies - Covers Global, European, Asia-Pacific & 11 individual country markets - Includes a five-year forecast of the industry Highlights Despite ongoing litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. in many of the world's markets and to the dismay of many big pharmaceutical companies, the global generics market is growing at a frenetic fre·net·ic or phre·net·ic also fre·net·i·cal or phre·net·i·cal adj. Wildly excited or active; frantic; frenzied. [Middle English frenetik, from Old French frenetique pace. The leading players in the global generics market include Apotex, IVAX Corporation IVAX Corporation was a United States public corporation focused on manufacturing and distributing generic pharmaceutical products. Ivax was acquired by the Israeli company Teva Pharmaceutical Industries in January 2006. External links
Generics companies still have to place a significant investment in to the development of a drug and in a somewhat paradoxical paradoxical different from what is expected; at variance with the established laws. paradoxical motion see paradoxical respiration (below). move are beginning to take out patents to protect their products. Why you should read this report? - Spot future trends and developments - Inform your business decisions - Add weight to presentations and marketing materials - Save time carrying out entry-level research Definition The value of the generics market consists of all sales of generics drugs at ex-manufacturers prices. The market does not include consumer healthcare products, nor animal healthcare. This publication defines a generic as a product, which is an officially approved copy of an original product whose patent has expired, marketed either as a brand or using the generic name generic name n. 1. The official nonproprietary name of a drug, under which it is licensed and identified by the manufacturer. 2. . This definition excludes multi-source copy products that make up much of markets such as India, Spain and Italy. All currency conversions have been calculated at a 2004 average. For the purpose of this report, Europe is deemed to consist of Belgium, France, Germany, Italy, Netherlands, Spain and the UK. Asia-Pacific consists of the Chinese and Japanese markets. The global market is deemed to be Asia-Pacific, Europe, Canada and the US. Company Profiles Include: Apotex, Inc. IVAX Corporation Merck & Co. Inc. Mylan Laboratories Inc. Novartis AG Novartis AG Swiss pharmaceutical company. It was formed through the 1996 merger of two Swiss firms: Ciba (see Ciba-Geigy) and Sandoz, a chemical company with interests in pharmaceuticals, nutrition, and agriculture. Teva Pharmaceutical Industries For more information visit http://www.researchandmarkets.com/reports/c26488 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion